Impact of the 2018 ASCO/CAP guidelines on HER2 fluorescence in situ hybridization interpretation in invasive breast cancers with immunohistochemically equivocal results

The American Society of Clinical Oncology (ASCO)/College of American Pathologists (CAP) recently issued updated guidelines on human epidermal growth factor receptor 2 (HER2) testing by fluorescence in situ hybridization (FISH) in invasive breast cancers. In this study, we aimed to investigate the im...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Bo, Ding, Wei, Sun, Ke, Wang, Xiaoling, Xu, Liming, Teng, Xiaodong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6854277/
https://www.ncbi.nlm.nih.gov/pubmed/31723206
http://dx.doi.org/10.1038/s41598-019-53003-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6854277/
https://www.ncbi.nlm.nih.gov/pubmed/31723206
http://dx.doi.org/10.1038/s41598-019-53003-w

Ejemplares similares